Nut Carcinoma
📧 Sign up to get email alerts when something new happens for Nut Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and potential efficacy of adding ZEN003694 to standard chemotherapy for adults and pedia…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating the safety and potential efficacy of combining ZEN003694 with abemaciclib in adults and 12-17-year-old ped…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Multicenter Retrospective Cohort of Pulmonary NUT Carcinoma
This clinical trial update describes a multicenter retrospective cohort study of pulmonary NUT carcinoma, with the study currently active bu…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
This is a screening study by TScan Therapeutics to collect samples for tumor-associated antigens, HLA typing, and HLA loss of heterozygosity…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Biology of Young Lung Cancer Study: The YOUNG LUNG Study
The YOUNG LUNG Study is currently recruiting, focusing on the biology of lung cancer in younger patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma [Phase 2]
Phase 2 clinical trial update for cemiplimab in incurable metastatic or unresectable NUT carcinoma; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: An International Study on Pediatric Patients With Rare Tumors.
An international pediatric clinical trial study focused on rare tumors is currently recruiting, covering multiple tumor types.
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer [Phase 2]
Multicenter, open-label, single-arm Phase II trial of NHWD-870 HCl in adults and adolescents with advanced NUT carcinoma, currently recruiti…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies [Phase 1]
This Phase 1 trial from Epigenetix, Inc. is evaluating a dual BET and CBP/p300 inhibitor across targeted advanced solid tumors and hematolog…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: BI 894999 First in Human Dose Finding Study in Advanced Malignancies [Phase 1]
First-in-human Phase 1 dose-finding study of BI 894999 in advanced malignancies has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers [Phase 1]
Phase 1 study of GSK525762 in NUT midline carcinoma and other cancers completed; results posted.